Recent Updates
Recently added Catalysts
BSX

Boston Scientific To Participate In 2013 Leerink Swann Global Healthcare Conference Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2013 Leerink Swann Global Healthcare Conference on February 13 in New...

Key Takeaway: NATICK, Mass. , Feb. 6, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the 2013 Leerink Swann Global Healthcare Conference on February 13 in New York . Boston Scientific Chief Financial Officer Jeff Capello will participate in a 25

Full Press Release Details

NATICK, Mass. , Feb. 6, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the 2013 Leerink Swann Global Healthcare Conference on February 13 in New York .
Boston Scientific Chief Financial Officer Jeff Capello will participate in a 25-minute question and answer session regarding the company beginning at approximately 2:00 p.m. EST .
A live webcast of the question and answer session will be available to interested parties on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors . Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
This webcast is being hosted by Leerink Swann. A replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.
About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit us at www.bostonscientific.com .
Steven Campanini 508-652-5740 (office) Media Relations Boston Scientific Corporation [email protected]
Michael Campbell 508-650-8023 (office) Investor Relations Boston Scientific Corporation [email protected]
SOURCE Boston Scientific Corporation

21 %

Last updated: Feb 6, 2013